poisar

Stock

Bio-Techne Corp TECH

$72.47+0.12%

Overview

TECH market data

Price History

TECH price chart · 1M
O
72.39
H
72.50
L
72.39
C
72.47
Vol
70,940.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$72.39
Previous Close
$72.38
Day High
$72.50
Day Low
$72.39
52 Week High
$72.53
52 Week Low
$43.08
7 Day Return
+0.35%
30 Day Return
+0.62%
90 Day Return
+40.34%
1 Year Return
+39.85%
Daily Notional Volume
$5.1M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
104.27
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$0.46
Diluted earnings per share over the trailing twelve months.
Beta
1.30
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
0.5%
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
9.0%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$43.20 – $72.62
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $11.3B · P/B 4.20 · P/S 9.34.

Company News

10 captured
Wells Fargo Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73Benzinga · Aug 13, 2026, 9:36 PM
Bio-Techne Q4 Adj. EPS $0.52, Inline, Sales $321.191M Beat $314.679M EstimateBenzinga · Aug 12, 2026, 10:41 AM
8-K filing — BIO-TECHNE Corp (TECH)SEC EDGAR · Aug 12, 2026, 10:30 AM
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible TakeoverBenzinga · Jul 10, 2026, 1:30 PM
RBC Capital Downgrades Bio-Techne to Sector Perform, Raises Price Target to $73Benzinga · Jul 9, 2026, 3:25 PM
Halper Sadeh LLC is Investigating Whether ACA, TECH, IRDM, LCII are Obtaining Fair Deals for their ShareholdersGlobenewswire Inc · Jul 6, 2026, 6:15 PM
TD Cowen Downgrades Bio-Techne to Hold, Raises Price Target to $73Benzinga · Jun 30, 2026, 1:40 PM
Benchmark Downgrades Bio-Techne to HoldBenzinga · Jun 30, 2026, 1:20 PM
Citigroup Downgrades Bio-Techne to Neutral, Raises Price Target to $73Benzinga · Jun 29, 2026, 1:15 PM
Stephens & Co. Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73Benzinga · Jun 26, 2026, 3:30 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock